Malaria Vaccines Market driven by growing prevalence of malaria
The malaria vaccines market has been growing significantly over the past decade due to the rising prevalence of malaria. According to WHO, around 229 million cases of malaria were reported globally in 2019. Malaria is caused by Plasmodium parasites that are transmitted to humans through the bites of infected Anopheles mosquitoes. The most affected regions include Africa south of the Sahara, Asia, and Latin America. Current therapies against malaria include antimalarial drugs, insecticides, and bed nets. However, these measures have limitations, thereby boosting the demand for vaccines that can offer effective prevention against all strains of malaria parasites.
The Global Malaria Vaccines Market is estimated to be valued at USD 620.0 Mn in 2025 and is expected to exhibit a CAGR of 12.7% over the forecast period 2025 to 2032.
Key Takeaways
Key players operating in the malaria vaccines market are GlaxoSmithKline plc and Sanaria. GlaxoSmithKline's candidate RTS,S/AS01 (Mosquirix) is currently the only vaccine approved for malaria.
The growing prevalence of malaria cases globally is driving the demand for effective vaccines. According to WHO, malaria accounted for 409,000 deaths globally in 2019, with children under 5 years being the most affected.
Leading manufacturers are expanding their presence in malaria endemic regions such as Africa and Asia Pacific to improve access to malaria vaccines portfolio and drive future Malaria Vaccines Market Size.
Market Drivers
The high disease burden of malaria globally is a major factor augmenting the malaria vaccines market. According to WHO, around 229 million malaria cases were reported in 2019 with an estimated death toll of 409,000. Most cases are concentrated in the African Region (94%), followed by the South-East Asia Region (3%) and the Eastern Mediterranean Region (2%). This growing prevalence is creating an urgent need for development and adoption of highly efficacious malaria vaccines.
Get More insights on Malaria Vaccines Market
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian